161 related articles for article (PubMed ID: 17389702)
21. Pre-operative management of patients with Graves' disease.
Chen H
Surgery; 2008 Feb; 143(2):292-3. PubMed ID: 18242347
[No Abstract] [Full Text] [Related]
22. Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.
Calissendorff J; Falhammar H
Endocrine; 2017 Dec; 58(3):467-473. PubMed ID: 29075974
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease.
Li J; Zhang J; Bai Y; Cheng Y; Cai S; Sun H
Chin Med Sci J; 1994 Jun; 9(2):104-7. PubMed ID: 8000055
[TBL] [Abstract][Full Text] [Related]
24. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
25. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
Saleh A; Fürst G; Feldkamp J; Godehardt E; Grust A; Mödder U
Ultrasound Med Biol; 2001 Aug; 27(8):1137-41. PubMed ID: 11527601
[TBL] [Abstract][Full Text] [Related]
26. Preoperative administration of excess iodide increases thyroid volume of patients with Graves' disease.
Yabuta T; Ito Y; Hirokawa M; Fukushima M; Inoue H; Tomoda C; Higashiyama T; Kihara M; Uruno T; Takamura Y; Kobayashi K; Miya A; Matsuzuka F; Miyauchi A
Endocr J; 2009; 56(3):371-5. PubMed ID: 19139595
[TBL] [Abstract][Full Text] [Related]
27. [The characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease].
Li J; Zhang J; Bai Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):170-4. PubMed ID: 7805159
[TBL] [Abstract][Full Text] [Related]
28. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases.
Caruso G; Attard M; Caronia A; Lagalla R
Eur J Radiol; 2000 Oct; 36(1):5-10. PubMed ID: 10996751
[TBL] [Abstract][Full Text] [Related]
29. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism.
Rangaswamy M; Padhy AK; Gopinath PG; Shukla NK; Gupta K; Kapoor MM
Nucl Med Commun; 1989 Sep; 10(9):679-84. PubMed ID: 2616107
[TBL] [Abstract][Full Text] [Related]
30. Jod-Basedow effect due to prolonged use of lugol solution-case report.
Leuştean L; Preda C; Ungureanu MC; Dănilă R; Mogoş V; Stefănescu C; Vulpoi C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1013-7. PubMed ID: 25581962
[TBL] [Abstract][Full Text] [Related]
31. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
32. Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease.
Varsamidis K; Varsamidou E; Mavropoulos G
Acta Radiol; 2000 Jan; 41(1):45-8. PubMed ID: 10665869
[TBL] [Abstract][Full Text] [Related]
33. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336
[TBL] [Abstract][Full Text] [Related]
34. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
Hari Kumar KV; Pasupuleti V; Jayaraman M; Abhyuday V; Rayudu B R; Modi KD
Endocr Pract; 2009; 15(1):6-9. PubMed ID: 19211390
[TBL] [Abstract][Full Text] [Related]
35. Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.
Randle RW; Bates MF; Long KL; Pitt SC; Schneider DF; Sippel RS
Surgery; 2018 Jan; 163(1):68-72. PubMed ID: 29108701
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
Wang CY; Chang TC
J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
[TBL] [Abstract][Full Text] [Related]
37. Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule.
Boostrom S; Richards ML
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):278-81. PubMed ID: 17275554
[TBL] [Abstract][Full Text] [Related]
38. Effect of preoperative potassium iodide administration on Graves' disease surgery: a propensity score analysis.
Barranquero AG; Muñoz de Nova JL; Gómez-Ramírez J; Valdés de Anca Á; Porrero B; Blanco Terés L; Corral S; Martín-Pérez E
Am J Surg; 2021 Nov; 222(5):959-963. PubMed ID: 33941360
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease.
Schuppert F; Taniguchi S; Schröder S; Dralle H; von zur Mühlen A; Kohn LD
J Clin Endocrinol Metab; 1996 Oct; 81(10):3622-8. PubMed ID: 8855812
[TBL] [Abstract][Full Text] [Related]
40. Power Doppler sonography in the diagnosis of Graves' disease.
Arslan H; Unal O; Algün E; Harman M; Sakarya ME
Eur J Ultrasound; 2000 May; 11(2):117-22. PubMed ID: 10781659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
